| Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma TF Cloughesy, AY Mochizuki, JR Orpilla, W Hugo, AH Lee, TB Davidson, ... Nature medicine 25 (3), 477-486, 2019 | 1087 | 2019 |
| Innate immune landscape in early lung adenocarcinoma by paired single-cell analyses Y Lavin, S Kobayashi, A Leader, ED Amir, N Elefant, C Bigenwald, ... Cell 169 (4), 750-765. e17, 2017 | 1052 | 2017 |
| Targeted next generation sequencing identifies markers of response to PD-1 blockade DB Johnson, GM Frampton, MJ Rioth, E Yusko, Y Xu, X Guo, RC Ennis, ... Cancer immunology research 4 (11), 959-967, 2016 | 470 | 2016 |
| ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial JM Wrangle, V Velcheti, MR Patel, E Garrett-Mayer, EG Hill, JG Ravenel, ... The Lancet Oncology 19 (5), 694-704, 2018 | 363 | 2018 |
| Fractionated radiation therapy stimulates antitumor immunity mediated by both resident and infiltrating polyclonal T-cell populations when combined with PD-1 blockade SJ Dovedi, EJ Cheadle, AL Popple, E Poon, M Morrow, R Stewart, ... Clinical Cancer Research 23 (18), 5514-5526, 2017 | 331 | 2017 |
| High throughput sequencing reveals a complex pattern of dynamic interrelationships among human T cell subsets C Wang, CM Sanders, Q Yang, HW Schroeder Jr, E Wang, F Babrzadeh, ... Proceedings of the National Academy of Sciences 107 (4), 1518-1523, 2010 | 312 | 2010 |
| A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European … AC Rawstron, C Fazi, A Agathangelidis, N Villamor, R Letestu, ... Leukemia 30 (4), 929-936, 2016 | 264 | 2016 |
| Adams PD; Kaelin WG Jr Transcriptional control by E2F. Semin Cancer Biol 6: 99-108 (1995) V Adams, W Kempf, S Hassam, J Briner, M Schmid, R Moos, M Pfaltz, ... Semin Cancer Biol 6, 99-108, 1995 | 223 | 1995 |
| Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells JF Fonteneau, DG Kavanagh, M Lirvall, C Sanders, TL Cover, N Bhardwaj, ... Blood 102 (13), 4448-4455, 2003 | 181 | 2003 |
| Dynamics of the cytotoxic T cell response to a model of acute viral infection WS DeWitt, RO Emerson, P Lindau, M Vignali, TM Snyder, C Desmarais, ... Journal of virology 89 (8), 4517-4526, 2015 | 153 | 2015 |
| Concurrent PD-1 blockade negates the effects of OX40 agonist antibody in combination immunotherapy through inducing T-cell apoptosis RK Shrimali, S Ahmad, V Verma, P Zeng, S Ananth, P Gaur, RM Gittelman, ... Cancer immunology research 5 (9), 755-766, 2017 | 146 | 2017 |
| Generation of high quantities of viral and tumor-specific human CD4+ and CD8+ T-cell clones using peptide pulsed mature dendritic cells JF Fonteneau, M Larsson, S Somersan, C Sanders, C Münz, WW Kwok, ... Journal of immunological methods 258 (1-2), 111-126, 2001 | 129 | 2001 |
| Efficiency of cross presentation of vaccinia virus‐derived antigens by human dendritic cells M Larsson, JF Fonteneau, S Somersan, C Sanders, K Bickham, ... European journal of immunology 31 (12), 3432-3442, 2001 | 125 | 2001 |
| The combined effect of FGFR inhibition and PD-1 blockade promotes tumor-intrinsic induction of antitumor immunity S Palakurthi, M Kuraguchi, SJ Zacharek, E Zudaire, W Huang, DM Bonal, ... Cancer immunology research 7 (9), 1457-1471, 2019 | 117 | 2019 |
| The effect of anti-CTLA4 treatment on peripheral and intra-tumoral T cells in patients with hepatocellular carcinoma D Agdashian, M ElGindi, C Xie, M Sandhu, D Pratt, DE Kleiner, WD Figg, ... Cancer Immunology, Immunotherapy 68, 599-608, 2019 | 111 | 2019 |
| TCR sequencing can identify and track glioma-infiltrating T cells after DC vaccination MS Hsu, S Sedighim, T Wang, JP Antonios, RG Everson, AM Tucker, L Du, ... Cancer immunology research 4 (5), 412-418, 2016 | 61 | 2016 |
| Fractal organization of the human T cell repertoire in health and after stem cell transplantation J Meier, C Roberts, K Avent, A Hazlett, J Berrie, K Payne, D Hamm, ... Biology of Blood and Marrow Transplantation 19 (3), 366-377, 2013 | 61 | 2013 |
| Aberrant expression of T-cell markers in acute myeloid leukemia RE Lewis, JM Cruse, CM Sanders, RN Webb, JL Suggs Experimental and molecular pathology 83 (3), 462-463, 2007 | 56 | 2007 |
| Targeted next generation sequencing identifies markers of response to PD-1 blockade. Cancer Immunol. Res. 2016; 4: 959–967. doi: 10.1158/2326-6066 DB Johnson, GM Frampton, MJ Rioth, E Yusko, Y Xu, X Guo, RC Ennis, ... CIR-16-0143.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 48 | |
| Opportunistic infections in patients with chronic lymphocytic leukemia following treatment with fludarabine C Sanders, EA Perez, HJ Lawrence American journal of hematology 39 (4), 314-315, 1992 | 46 | 1992 |
